Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Clinical applications of interferon-γ releasing assays for cytomegalovirus to differentiate cytomegalovirus disease from bystander activation: a pilot proof-of-concept study.

Kim SH, Lee HS, Lee HJ, Kim SM, Shin S, Park SH, Kim KJ, Kim YH, Sung H, Lee SO, Choi SH, Yang SK, Kim YS, Woo JH, Han DJ.

Korean J Intern Med. 2017 Sep;32(5):900-909. doi: 10.3904/kjim.2015.354. Epub 2017 Aug 23.

2.

Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn's disease.

Szymanska E, Dadalski M, Grajkowska W, Szymanska S, Pronicki M, Kierkus J.

Prz Gastroenterol. 2017;12(1):44-48. doi: 10.5114/pg.2016.64746. Epub 2016 Dec 20.

3.

Second Korean guidelines for the management of ulcerative colitis.

Choi CH, Moon W, Kim YS, Kim ES, Lee BI, Jung Y, Yoon YS, Lee H, Park DI, Han DS; IBD Study Group of the Korean Association for the Study of Intestinal Diseases.

Intest Res. 2017 Jan;15(1):7-37. doi: 10.5217/ir.2017.15.1.7. Epub 2017 Jan 31. Review.

4.

The impact of induction therapy with three doses of infliximab on deep histological healing in paediatric patients with active Crohn's disease.

Szymanska E, Dadalski M, Szymanska S, Grajkowska W, Pronicki M, Kierkus J.

Prz Gastroenterol. 2016;11(3):176-180. Epub 2016 Feb 8.

5.

Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Zhao X, Li N, Ren Y, Ma T, Wang C, Wang J, You S.

PLoS One. 2016 Aug 8;11(8):e0160500. doi: 10.1371/journal.pone.0160500. eCollection 2016.

6.

Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire survey.

Ueno F, Nakayama Y, Hagiwara E, Kurimoto S, Hibi T.

J Gastroenterol. 2017 May;52(5):555-567. doi: 10.1007/s00535-016-1241-x. Epub 2016 Jul 28.

7.

Coordinated Hospital-Home Fecal Microbiota Transplantation via Percutaneous Endoscopic Cecostomy for Recurrent Steroid-Dependent Ulcerative Colitis.

Ni X, Fan S, Zhang Y, Wang Z, Ding L, Li Y, Li J.

Gut Liver. 2016 Nov 15;10(6):975-980. doi: 10.5009/gnl15456.

8.

The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease.

Lee HW, Chung SH, Moon CM, Che X, Kim SW, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH.

Medicine (Baltimore). 2016 Jun;95(23):e3772. doi: 10.1097/MD.0000000000003772.

9.

Expression of Beclin1 in the colonic mucosa tissues of patients with ulcerative colitis.

Hao X, Yang B, Liu X, Yang H, Liu X.

Int J Clin Exp Med. 2015 Nov 15;8(11):21098-105. eCollection 2015.

10.

Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study.

Suzuki Y, Iida M, Ito H, Saida I, Hibi T.

Intest Res. 2016 Jan;14(1):50-9. doi: 10.5217/ir.2016.14.1.50. Epub 2016 Jan 26.

11.

A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis.

Kongnyuy M, Frye T, George AK, Kilchevsky A, Iyer A, Kadakia M, Muthigi A, Turkbey B, Wood BJ, Pinto PA.

Case Rep Urol. 2015;2015:676930. doi: 10.1155/2015/676930. Epub 2015 Dec 30. Erratum in: Case Rep Urol. 2016;2016:3012941.

12.

Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease.

Chung SH, Lee HW, Kim SW, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH.

Gut Liver. 2016 Jul 15;10(4):574-80. doi: 10.5009/gnl15209.

13.

Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance.

Wang ZH, Fang JY.

Gastrointest Tumors. 2014 Aug;1(3):146-54. doi: 10.1159/000365309. Epub 2014 Jul 18. Review.

14.

Animal models to study acute and chronic intestinal inflammation in mammals.

Jiminez JA, Uwiera TC, Douglas Inglis G, Uwiera RR.

Gut Pathog. 2015 Nov 10;7:29. doi: 10.1186/s13099-015-0076-y. eCollection 2015. Review.

15.

Expression of Transcription Factor FOXO3a is Decreased in Patients with Ulcerative Colitis.

Min M, Yang J, Yang YS, Liu Y, Liu LM, Xu Y.

Chin Med J (Engl). 2015 Oct 20;128(20):2759-63. doi: 10.4103/0366-6999.167314.

16.

Histological healing after infliximab induction therapy in children with ulcerative colitis.

Wiernicka A, Szymanska S, Cielecka-Kuszyk J, Dadalski M, Kierkus J.

World J Gastroenterol. 2015 Oct 7;21(37):10654-61. doi: 10.3748/wjg.v21.i37.10654.

17.

Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy.

Yassin MA, Nashwan AJ, Soliman AT, Yousif A, Moustafa A, AlBattah A, Mohamed SF, Mudawi DS, Elkourashy S, Asaari DR, Gutierrez HL, Almusharaf M, Hussein RM, Moustafa AH, Derhoubi HE, Boukhris S, Kohla S, AlDewik N.

Clin Med Insights Case Rep. 2015 Aug 26;8:77-81. doi: 10.4137/CCRep.S25327. eCollection 2015.

18.

Oral Manifestations of Crohn's Disease: A Case Report and Review of the Literature.

Woo VL.

Case Rep Dent. 2015;2015:830472. doi: 10.1155/2015/830472. Epub 2015 Jul 9.

19.

Health-related quality of life in Chinese patients with mild and moderately active ulcerative colitis.

Zheng K, Zhang S, Wang C, Zhao W, Shen H.

PLoS One. 2015 Apr 27;10(4):e0124211. doi: 10.1371/journal.pone.0124211. eCollection 2015.

20.

Tools for primary care management of inflammatory bowel disease: do they exist?

Bennett AL, Munkholm P, Andrews JM.

World J Gastroenterol. 2015 Apr 21;21(15):4457-65. doi: 10.3748/wjg.v21.i15.4457. Review.

Supplemental Content

Support Center